The 2015 World Health Organization Classification of Lung Tumors
Tóm tắt
Từ khóa
Tài liệu tham khảo
Travis, 2015
Fritz, 2000
Travis, 2004
World Health Organization, 1967
World Health Organization, 1981
Travis, 1999
Travis, 2011, The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification, J Thoracic Oncol, 6, 244, 10.1097/JTO.0b013e318206a221
Travis, 2013, Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification, Arch Pathol Lab Med, 137, 668, 10.5858/arpa.2012-0263-RA
Ou, 2009, Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies, J Thorac Oncol, 4, 1202, 10.1097/JTO.0b013e3181b28fb9
Loo, 2010, Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens, J Thorac Oncol, 5, 442, 10.1097/JTO.0b013e3181d40fac
Nicholson, 2010, Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis, J Thorac Oncol, 5, 436, 10.1097/JTO.0b013e3181c6ed9b
Edwards, 2000, Preoperative histological classification of primary lung cancer: accuracy of diagnosis and use of the non-small cell category, J Clin Pathol, 53, 537, 10.1136/jcp.53.7.537
Travis, 2010, Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift, J Thorac Oncol, 5, 411, 10.1097/JTO.0b013e3181d57f6e
Turner, 2012, Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray, Arch Pathol Lab Med, 136, 163, 10.5858/arpa.2011-0320-OA
Bishop, 2012, p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma, Mod Pathol, 25, 405, 10.1038/modpathol.2011.173
Pelosi, 2012, ΔN63 (p40) and thyroid transcription factor-1 immunoreactivity on small biopsies or cellblocks for typing non-small cell lung cancer: a novel two-hit, sparing-material approach, J Thorac Oncol, 7, 281, 10.1097/JTO.0b013e31823815d3
Nonaka, 2012, A study of ΔN63 expression in lung non-small cell carcinomas, Am J Surg Pathol, 36, 895, 10.1097/PAS.0b013e3182498f2b
Rekhtman, 2013, Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma, Mod Pathol, 26, 511, 10.1038/modpathol.2012.195
Travis, 2013, New pathologic classification of lung cancer: relevance for clinical practice and clinical trials, J Clin Oncol, 31, 992, 10.1200/JCO.2012.46.9270
Cancer Genome Atlas Research Network, 2012, Comprehensive genomic characterization of squamous cell lung cancers, Nature, 489, 519, 10.1038/nature11404
Cancer Genome Atlas Research Network, 2014, Comprehensive molecular profiling of lung adenocarcinoma, Nature, 511, 543, 10.1038/nature13385
Clinical Lung Cancer Genome Project (CLCGP), 2013, A genomics-based classification of human lung tumors, Sci Transl Med, 5, 209ra153
Barletta, 2010, Prognostic significance of grading in lung adenocarcinoma, Cancer, 116, 659, 10.1002/cncr.24831
Kadota, 2012, A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma, Mod Pathol, 25, 1117, 10.1038/modpathol.2012.58
Nakazato, 2013, Interobserver agreement in the nuclear grading of primary pulmonary adenocarcinoma, J Thorac Oncol, 8, 736, 10.1097/JTO.0b013e318288dbd8
Nakazato, 2010, Nuclear grading of primary pulmonary adenocarcinomas: correlation between nuclear size and prognosis, Cancer, 116, 2011, 10.1002/cncr.24948
Sica, 2010, A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors, Am J Surg Pathol, 34, 1155, 10.1097/PAS.0b013e3181e4ee32
Yoshizawa, 2011, Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases, Mod Pathol, 24, 653, 10.1038/modpathol.2010.232
Warth, 2012, The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival, J Clin Oncol, 30, 1438, 10.1200/JCO.2011.37.2185
Duhig, 2015, Mitosis trumps T stage and proposed international association for the study of lung cancer/American thoracic society/European respiratory society classification for prognostic value in resected stage 1 lung adenocarcinoma, J Thorac Oncol, 10, 673, 10.1097/JTO.0000000000000446
von der Thüsen, 2013, Prognostic significance of predominant histologic pattern and nuclear grade in resected adenocarcinoma of the lung: potential parameters for a grading system, J Thorac Oncol, 8, 37, 10.1097/JTO.0b013e318276274e
Kadota, 2014, Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes, J Thorac Oncol, 9, 1126, 10.1097/JTO.0000000000000253
Sigel, 2012, Predicting pulmonary adenocarcinoma outcome based on a cytology grading system, Cancer Cytopathol, 120, 35, 10.1002/cncy.20185
Kadota, 2015, Tumor budding correlates with protumor immune microenvironment and is an independent prognostic factor for recurrence of stage I lung adenocarcinoma, Chest, 10.1378/chest.14-3005
Yamaguchi, 2010, Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness, J Thorac Oncol, 5, 1361, 10.1097/JTO.0b013e3181eaf2f3
Taira, 2012, Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung, Lung Cancer, 76, 423, 10.1016/j.lungcan.2011.11.010
Travis, 2013, Diagnosis of lung adenocarcinoma in resected specimens: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification, Arch Pathol Lab Med, 137, 685, 10.5858/arpa.2012-0264-RA
Kadota, 2015, Reevaluation and reclassification of resected lung carcinomas originally diagnosed as squamous cell carcinoma using immunohistochemical analysis, Am J Surg Pathol, 10.1097/PAS.0000000000000439
Rekhtman, 2012, Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations, Clin Cancer Res, 18, 1167, 10.1158/1078-0432.CCR-11-2109
Kadota, 2014, Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease, Am J Surg Pathol, 38, 448, 10.1097/PAS.0000000000000134
Lim, 2013, Persistent pure ground-glass opacity lung nodules ≥ 10 mm in diameter at CT scan: histopathologic comparisons and prognostic implications, Chest, 144, 1291, 10.1378/chest.12-2987
Lee, 2014, Pure ground-glass opacity neoplastic lung nodules: histopathology, imaging, and management, AJR Am J Roentgenol, 202, W224, 10.2214/AJR.13.11819
Isaka, 2014, Comparison between CT tumor size and pathological tumor size in frozen section examinations of lung adenocarcinoma, Lung Cancer, 85, 40, 10.1016/j.lungcan.2014.03.023
Naidich, 2013, Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society, Radiology, 266, 304, 10.1148/radiol.12120628
Girard, 2009, Comprehensive histologic assessment helps to differentiate multiple lung primary non-small cell carcinomas from metastases, Am J Surg Pathol, 33, 1752, 10.1097/PAS.0b013e3181b8cf03
Kadota, 2014, The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype, Mod Pathol, 27, 690, 10.1038/modpathol.2013.188
Mackinnon, 2014, Cribriform adenocarcinoma of the lung: clinicopathologic, immunohistochemical, and molecular analysis of 15 cases of a distinctive morphologic subtype of lung adenocarcinoma, Mod Pathol, 27, 1063, 10.1038/modpathol.2013.227
Warth, 2015, Prognostic impact and clinicopathological correlations of the cribriform pattern in pulmonary adenocarcinoma, J Thorac Oncol, 10, 638, 10.1097/JTO.0000000000000490
Thunnissen, 2012, Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study, Mod Pathol, 25, 1574, 10.1038/modpathol.2012.106
Warth, 2012, Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification, Virchows Arch, 461, 185, 10.1007/s00428-012-1263-6
Nitadori, 2013, Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller, J Natl Cancer Inst, 105, 1212, 10.1093/jnci/djt166
Onozato, 2013, Tumor islands in resected early-stage lung adenocarcinomas are associated with unique clinicopathologic and molecular characteristics and worse prognosis, Am J Surg Pathol, 37, 287, 10.1097/PAS.0b013e31826885fb
Kadota, 2015, Tumor spread through air spaces is an important pattern of invasion and impacts the frequency and location of recurrences after limited resection for small stage I lung adenocarcinomas, J Thorac Oncol, 10, 806, 10.1097/JTO.0000000000000486
Warth, 2015, Prognostic impact of intraalveolar tumor spread in pulmonary adenocarcinoma, Am J Surg Pathol, 39, 793, 10.1097/PAS.0000000000000409
Loukeri, 2015, Metachronous and synchronous primary lung cancers: diagnostic aspects, surgical treatment, and prognosis, Clin Lung Cancer, 16, 15, 10.1016/j.cllc.2014.07.001
Klempner, 2015, The clinical use of genomic profiling to distinguish intrapulmonary metastases from synchronous primaries in non-small-cell lung cancer: a mini-review, Clin Lung Cancer, 10.1016/j.cllc.2015.03.004
Murphy, 2014, Identification of independent primary tumors and intrapulmonary metastases using DNA rearrangements in non-small-cell lung cancer, J Clin Oncol, 32, 4050, 10.1200/JCO.2014.56.7644
Girard, 2010, Use of epidermal growth factor receptor/Kirsten rat sarcoma 2 viral oncogene homolog mutation testing to define clonal relationships among multiple lung adenocarcinomas: comparison with clinical guidelines, Chest, 137, 46, 10.1378/chest.09-0325
Girard, 2009, Genomic and mutational profiling to assess clonal relationships between multiple non-small cell lung cancers, Clin Cancer Res, 15, 5184, 10.1158/1078-0432.CCR-09-0594
Xue, 2013, Diagnosis of multiple primary lung cancer: a systematic review, J Int Med Res, 41, 1779, 10.1177/0300060513504707
Song, 2013, Prognostic value of the IASLC/ATS/ERS classification in stage I lung adenocarcinoma patients–based on a hospital study in China, Eur J Surg Oncol, 39, 1262, 10.1016/j.ejso.2013.08.026
Takahashi, 2014, Tumor invasiveness as defined by the newly proposed IASLC/ATS/ERS classification has prognostic significance for pathologic stage IA lung adenocarcinoma and can be predicted by radiologic parameters, J Thorac Cardiovasc Surg, 147, 54, 10.1016/j.jtcvs.2013.08.058
Tsuta, 2013, The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations, Lung Cancer, 81, 371, 10.1016/j.lungcan.2013.06.012
Yanagawa, 2013, New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma, J Thorac Oncol, 8, 612, 10.1097/JTO.0b013e318287c3eb
Yanagawa, 2014, The correlation of the International Association for the Study of Lung Cancer (IASLC)/American Thoracic Society (ATS)/European Respiratory Society (ERS) classification with prognosis and EGFR mutation in lung adenocarcinoma, Ann Thorac Surg, 98, 453, 10.1016/j.athoracsur.2014.04.108
Yoshizawa, 2013, Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients, J Thorac Oncol, 8, 52, 10.1097/JTO.0b013e3182769aa8
Woo, 2012, Prognostic value of the IASLC/ATS/ERS classification of lung adenocarcinoma in stage I disease of Japanese cases, Pathol Int, 62, 785, 10.1111/pin.12016
Cha, 2014, Micropapillary and solid subtypes of invasive lung adenocarcinoma: clinical predictors of histopathology and outcome, J Thorac Cardiovasc Surg, 147, 921, 10.1016/j.jtcvs.2013.09.045
Nitadori, 2013, Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2 cm or smaller, J Natl Cancer Inst, 105, 1212, 10.1093/jnci/djt166
Ujiie, 2015, Solid predominant histologic subtype in resected stage I lung adenocarcinoma is an independent predictor of early, extrathoracic, multisite recurrence and of poor postrecurrence survival, J Clin Oncol, 10.1200/JCO.2015.60.9818
Tsao, 2015, Subtype classification of lung adenocarcinoma predicts benefit from adjuvant chemotherapy in patients undergoing complete resection, J Clin Oncol, 10.1200/JCO.2014.58.8335
Brambilla, 2014, Lung squamous cell carcinomas with basaloid histology represent a specific molecular entity, Clin Cancer Res, 20, 5777, 10.1158/1078-0432.CCR-14-0459
Barnes, 2005
Brambilla, 1992, Basal cell (basaloid) carcinoma of the lung: a new morphologic and phenotypic entity with separate prognostic significance, Hum Pathol, 23, 993, 10.1016/0046-8177(92)90260-A
Moro-Sibilot, 2008, Lung carcinomas with a basaloid pattern: a study of 90 cases focusing on their poor prognosis, Eur Respir J, 31, 854, 10.1183/09031936.00058507
Kim, 2003, Basaloid carcinoma of the lung: a really dismal histologic variant?, Ann Thorac Surg, 76, 1833, 10.1016/S0003-4975(03)01296-7
Wang, 2011, Analysis on the clinical features of 22 basaloid squamous cell carcinoma of the lung, J Cardiothorac Surg, 6, 10, 10.1186/1749-8090-6-10
Herbst, 2015, Lung master protocol (Lung-MAP)-A biomarker-driven protocol for accelerating development of therapies for squamous cell lung cancer: SWOG S1400, Clin Cancer Res, 21, 1514, 10.1158/1078-0432.CCR-13-3473
Hwang, 2014, Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma, Arch Pathol Lab Med, 138, 626, 10.5858/arpa.2013-0179-OA
Rossi, 2014, Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology, Virchows Arch, 464, 61, 10.1007/s00428-013-1501-6
2013, (NGM) CLCGPCNGM. A genomics-based classification of human lung tumors, Sci Transl Med, 5, 209ra153
Caplin, 2015, Pulmonary neuroendocrine (carcinoid) tumors: European neuroendocrine tumor society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoid, Ann Oncol, 26, 1604, 10.1093/annonc/mdv041
Fernandez-Cuesta, 2014, Frequent mutations in chromatin-remodelling genes in pulmonary carcinoids, Nat Commun, 5, 3518, 10.1038/ncomms4518
Pelosi, 2014, Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice, J Thorac Oncol, 9, 273, 10.1097/JTO.0000000000000092
Pelosi, 2005, Typical and atypical pulmonary carcinoid tumor overdiagnosed as small-cell carcinoma on biopsy specimens: a major pitfall in the management of lung cancer patients, Am J Surg Pathol, 29, 179, 10.1097/01.pas.0000149690.75462.29
Walts, 2012, Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors, Mod Pathol, 25, 1258, 10.1038/modpathol.2012.81
Travis, 1998, Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid, Am J Surg Pathol, 22, 934, 10.1097/00000478-199808000-00003
Yendamuri, 2012, Outcomes of sarcomatoid carcinoma of the lung: a surveillance, epidemiology, and end results database analysis, Surgery, 152, 397, 10.1016/j.surg.2012.05.007
Italiano, 2009, EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: implications for anti-EGFR treatment of a rare lung malignancy, Int J Cancer, 125, 2479, 10.1002/ijc.24610
Pelosi, 2004, K-ras gene mutational analysis supports a monoclonal origin of biphasic pleomorphic carcinoma of the lung, Mod Pathol, 17, 538, 10.1038/modpathol.3800058
Chang, 2011, EGFR and p53 status of pulmonary pleomorphic carcinoma: implications for EGFR tyrosine kinase inhibitors therapy of an aggressive lung malignancy, Ann Surg Oncol, 18, 2952, 10.1245/s10434-011-1621-7
Kaira, 2010, Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis, J Thorac Oncol, 5, 460, 10.1097/JTO.0b013e3181ce3e3c
Leone, 2011, Identification of EGFR mutations in lung sarcomatoid carcinoma, Int J Cancer, 128, 732, 10.1002/ijc.25335
Lee, 2011, Molecular profiles of EGFR, K-ras, c-met, and FGFR in pulmonary pleomorphic carcinoma, a rare lung malignancy, J Cancer Res Clin Oncol, 137, 1203, 10.1007/s00432-011-0986-0
Dacic, 2002, Molecular pathogenesis of pulmonary carcinosarcoma as determined by microdis-section-based allelotyping, Am J Surg Pathol, 26, 510, 10.1097/00000478-200204000-00015
Holst, 1997, p53 and K-ras mutational genotyping in pulmonary carcinosarcoma, spindle cell carcinoma, and pulmonary blastoma: implications for histogenesis, Am J Surg Pathol, 21, 801, 10.1097/00000478-199707000-00008
Pardo, 2008, Primary mixed squamous carcinoma and osteosarcoma (carcinosarcomas) of the lung have a CGH mapping similar to primitive squamous carcinomas and osteosarcomas, Diagn Mol Pathol, 17, 151, 10.1097/PDM.0b013e31815d05b3
Pelosi, 2012, Multiparametric molecular characterization of pulmonary sarcomatoid carcinoma reveals a nonrandom amplification of anaplastic lymphoma kinase (ALK) gene, Lung Cancer, 77, 507, 10.1016/j.lungcan.2012.05.093
Toyokawa, 2013, The first case of lung carcinosarcoma harboring in-frame deletions at exon19 in the EGFR gene, Lung Cancer, 81, 491, 10.1016/j.lungcan.2013.06.013
Macher-Goeppinger, 2011, Expression and mutation analysis of EGFR, c-KIT, and β-catenin in pulmonary blastoma, J Clin Pathol, 64, 349, 10.1136/jcp.2010.085696
Nakatani, 2002, Aberrant nuclear localization and gene mutation of beta-catenin in low-grade adenocarcinoma of fetal lung type: up-regulation of the Wnt signaling pathway may be a common denominator for the development of tumors that form morules, Mod Pathol, 15, 617, 10.1038/modpathol.3880575
Sekine, 2003, Beta-catenin mutations in pulmonary blastomas: association with morule formation, J Pathol, 200, 214, 10.1002/path.1352
Bodner, 1996, Mutations in the p53 gene in pulmonary blastomas: immunohistochemical and molecular studies, Hum Pathol, 27, 1117, 10.1016/S0046-8177(96)90302-0
Bauer, 2012, Clinicopathologic features and long-term outcomes of NUT midline carcinoma, Clin Cancer Res, 18, 5773, 10.1158/1078-0432.CCR-12-1153
French, 2004, Midline carcinoma of children and young adults with NUT rearrangement, J Clin Oncol, 22, 4135, 10.1200/JCO.2004.02.107
French, 2010, Demystified molecular pathology of NUT midline carcinomas, J Clin Pathol, 63, 492, 10.1136/jcp.2007.052902
Haack, 2009, Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody, Am J Surg Pathol, 33, 984, 10.1097/PAS.0b013e318198d666
Schwartz, 2011, Differentiation of NUT midline carcinoma by epigenomic reprogramming, Cancer Res, 71, 2686, 10.1158/0008-5472.CAN-10-3513
Devouassoux-Shisheboran, 2000, A clinicopathologic study of 100 cases of pulmonary sclerosing hemangioma with immunohistochemical studies: TTF-1 is expressed in both round and surface cells, suggesting an origin from primitive respiratory epithelium, Am J Surg Pathol, 24, 906, 10.1097/00000478-200007000-00002
Chan, 2000, Pulmonary sclerosing hemangioma consistently expresses thyroid transcription factor-1 (TTF-1): a new clue to its histogenesis, Am J Surg Pathol, 24, 1531, 10.1097/00000478-200011000-00009
Niho, 1998, Monoclonality of both pale cells and cuboidal cells of sclerosing hemangioma of the lung, Am J Pathol, 152, 1065
Dal Cin, 1993, Rearrangement of 12q14–15 in pulmonary chondroid hamartoma, Genes Chromosomes Cancer, 8, 131, 10.1002/gcc.2870080211
Fletcher, 1995, Cytogenetic and histologic findings in 17 pulmonary chondroid hamartomas: evidence for a pathogenetic relationship with lipomas and leiomyomas, Genes Chromosomes Cancer, 12, 220, 10.1002/gcc.2870120310
Xiao, 1997, HMGI(Y) activation by chromosome 6p21 rearrangements in multilineage mesenchymal cells from pulmonary hamartoma, Am J Pathol, 150, 901
Tomashefski, 1982, Benign endobronchial mesenchymal tumors: their relationship to parenchymal pulmonary hamartomas, Am J Surg Pathol, 6, 531, 10.1097/00000478-198209000-00005
Carsillo, 2000, Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis, Proc Natl Acad Sci U S A, 97, 6085, 10.1073/pnas.97.11.6085
Martignoni, 2010, Molecular pathology of lymphangioleiomyomatosis and other perivascular epithelioid cell tumors, Arch Pathol Lab Med, 134, 33, 10.5858/2008-0542-RAR1.1
D’Armiento, 2007, Identification of the benign mesenchymal tumor gene HMGA2 in lymphangiomyomatosis, Cancer Res, 67, 1902, 10.1158/0008-5472.CAN-06-1122
McCormack, 2012, Lymphangioleiomyomatosis: calling it what it is: a low-grade, destructive, metastasizing neoplasm, Am J Respir Crit Care Med, 186, 1210, 10.1164/rccm.201205-0848OE
Flieder, 1997, Clear cell “sugar” tumor of the lung: association with lymphangioleiomyomatosis and multifocal micronodular pneumocyte hyperplasia in a patient with tuberous sclerosis, Am J Surg Pathol, 21, 1242, 10.1097/00000478-199710000-00017
Pileri, 2004, Clear-cell proliferation of the lung with lymphangioleiomyomatosis-like change, Histopathology, 44, 156, 10.1111/j.1365-2559.2004.01788.x
Lawson, 2012, Successful treatment of progressive diffuse PEComatosis, Eur Respir J, 40, 1578, 10.1183/09031936.00076411
Maruyama, 2001, Multifocal micronodular pneumocyte hyperplasia and lymphangioleiomyomatosis in tuberous sclerosis with a TSC2 gene, Mod Pathol, 14, 609, 10.1038/modpathol.3880359
Gaffey, 1997, Clear cell tumors of the lower respiratory tract, Semin Diagn Pathol, 14, 222
Chen, 2014, Clear cell tumor of the lung: a retrospective analysis, Am J Med Sci, 347, 50, 10.1097/MAJ.0b013e318295c821
Gaffey, 1991, Clear cell tumor of the lung. Immunohistochemical and ultrastructural evidence of melanogenesis, Am J Surg Pathol, 15, 644, 10.1097/00000478-199107000-00005
Lantuejoul, 1997, Clear cell tumor of the lung: an immunohistochemical and ultrastructural study supporting a pericytic differentiation, Mod Pathol, 10, 1001
Inoki, 2005, Dysregulation of the TSC-mTOR pathway in human disease, Nat Genet, 37, 19, 10.1038/ng1494
Anderson, 2015, Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1–CAMTA1 fusions, Am J Surg Pathol, 39, 132, 10.1097/PAS.0000000000000346
Lau, 2011, Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer, Chest, 140, 1312, 10.1378/chest.11-0039
Mendlick, 2001, Translocation t(1;3) (p36.3;q25) is a nonrandom aberration in epithelioid hemangioendothelioma, Am J Surg Pathol, 25, 684, 10.1097/00000478-200105000-00019
Errani, 2011, A novel WWTR1–CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites, Genes Chromosomes Cancer, 50, 644, 10.1002/gcc.20886
Patel, 2015, Molecular characterization of epithelioid haemangioendotheliomas identifies novel WWTR1–CAMTA1 fusion variants, Histopathology, 10.1111/his.12697
Tanas, 2011, Identification of a disease-defining gene fusion in epithelioid hemangioendothelioma, Sci Transl Med, 3, 98ra82, 10.1126/scitranslmed.3002409
Antonescu, 2013, Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma, Genes Chromosomes Cancer, 52, 775, 10.1002/gcc.22073
Bagan, 2006, Prognostic factors and surgical indications of pulmonary epithelioid hemangioendothelioma: a review of the literature, Ann Thorac Surg, 82, 2010, 10.1016/j.athoracsur.2006.06.068
Nicholson, 1999, Malignant myxoid endobronchial tumour: a report of two cases with a unique histological pattern, Histopathology, 35, 313, 10.1046/j.1365-2559.1999.00724.x
Thway, 2011, Primary pulmonary myxoid sarcoma with EWSR1-CREB1 fusion: a new tumor entity, Am J Surg Pathol, 35, 1722, 10.1097/PAS.0b013e318227e4d2
Thway, 2012, Endobronchial pulmonary angiomatoid fibrous histiocytoma: two cases with EWSR1-CREB1 and EWSR1-ATF1 fusions, Am J Surg Pathol, 36, 883, 10.1097/PAS.0b013e31824b1ee0
Thway, 2012, Tumors with EWSR1-CREB1 and EWSR1-ATF1 fusions: the current status, Am J Surg Pathol, 36, e1, 10.1097/PAS.0b013e31825485c5
Fletcher, 2013, Myoepithelioma/myoepithelial carcinoma/mixed tumor, 208
Hornick, 2003, Myoepithelial tumors of soft tissue: a clinicopathologic and immunohistochemical study of 101 cases with evaluation of prognostic parameters, Am J Surg Pathol, 27, 1183, 10.1097/00000478-200309000-00001
Hysi, 2011, Primary pulmonary myoepithelial carcinoma, Interact Cardiovasc Thorac Surg, 13, 226, 10.1510/icvts.2011.270934
Kourda, 2010, Benign myoepithelioma of the lung - a case report and review of the literature, Cases J, 3, 25, 10.1186/1757-1626-3-25
Masuya, 2005, Myoepithelial carcinoma of the lung, Eur J Cardiothorac Surg, 28, 775, 10.1016/j.ejcts.2005.08.003
Sarkaria, 2011, Primary myoepithelial carcinoma of the lung: a rare entity treated with parenchymal sparing resection, J Cardiothorac Surg, 6, 27, 10.1186/1749-8090-6-27
Antonescu, 2010, EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene, Genes Chromosomes Cancer, 49, 1114, 10.1002/gcc.20819
Cavalli, 2013, The multifaceted clinical presentations and manifestations of Erdheim–Chester disease: comprehensive review of the literature and of 10 new cases, Ann Rheum Dis, 72, 1691, 10.1136/annrheumdis-2012-202542
Diamond, 2014, Consensus guidelines for the diagnosis and clinical management of Erdheim–Chester disease, Blood, 124, 483, 10.1182/blood-2014-03-561381
Arnaud, 2010, Pulmonary involvement in Erdheim–Chester disease: a single-center study of thirty-four patients and a review of the literature, Arthritis Rheum, 62, 3504, 10.1002/art.27672
Brun, 2010, Erdheim–Chester disease: CT findings of thoracic involvement, Eur Radiol, 20, 2579, 10.1007/s00330-010-1830-7
Rush, 2000, Pulmonary pathology of Erdheim–Chester disease [In Process Citation], ModPathol, 13, 747
Haroche, 2012, High prevalence of BRAF V600E mutations in Erdheim–Chester disease but not in other non-Langerhans cell histiocytoses, Blood, 120, 2700, 10.1182/blood-2012-05-430140
Chetritt, 1999, Chester–Erdheim disease: a neoplastic disorder, Hum Pathol, 30, 1093, 10.1016/S0046-8177(99)90228-9
Vencio, 2007, Clonal cytogenetic abnormalities in Erdheim–Chester disease, Am J Surg Pathol, 31, 319, 10.1097/01.pas.0000213366.33627.a0
Gong, 2009, Clonal status and clinicopathological feature of Erdheim–Chester disease, Pathol Res Pract, 205, 601, 10.1016/j.prp.2009.02.004
Tzoulis, 2015, Excellent response of intramedullary Erdheim–Chester disease to vemurafenib: a case report, BMC Res Notes, 8, 171, 10.1186/s13104-015-1135-7